Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands

• Published in: International journal of molecular sciences Vol. 25; no. 15; p. 8226
• Main Authors: Scarano, Naomi, Espinoza, Stefano, Brullo, Chiara, Cichero, Elena
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-08-2024
• Subjects: Amines; Animals; Binding sites; Cancer; Chemotherapy; docking; Dopamine; drug design; Drug discovery; Drug Discovery - methods; Humans; Ligands; Methods; Molecular Docking Simulation; molecular modeling; mutagenesis; Physiological aspects; Protein Binding; Receptors, G-Protein-Coupled - chemistry; Receptors, G-Protein-Coupled - metabolism; Schizophrenia; Serotonin; Software; TAAR1; TAAR5; docking; TAAR5; drug design; molecular modeling; TAAR1; mutagenesis
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25158226

G-protein-coupled receptors (GPCRs) represent a family of druggable targets when treating several diseases and continue to be a leading part of the drug discovery process. Trace amine-associated receptors (TAARs) are GPCRs involved in many physiological functions with TAAR1 having important roles within the central nervous system (CNS). By using homology modeling methods, the responsiveness of TAAR1 to endogenous and synthetic ligands has been explored. In addition, the discovery of different chemo-types as selective murine and/or human TAAR1 ligands has helped in the understanding of the species-specificity preferences. The availability of TAAR1-ligand complexes sheds light on how different ligands bind TAAR1. TAAR5 is considered an olfactory receptor but has specific involvement in some brain functions. In this case, the drug discovery effort has been limited. Here, we review the successful computational efforts developed in the search for novel TAAR1 and TAAR5 ligands. A specific focus on applying structure-based and/or ligand-based methods has been done. We also give a perspective of the experimental data available to guide the future drug design of new ligands, probing species-specificity preferences towards more selective ligands. Hints for applying repositioning approaches are also discussed.